Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 27, 2024Journal of Hematology & OncologyOpen Access

Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial

View Full Paper
Ask AI
Bookmark
Share

Authors

SNSwati NaikSt. Jude Children's Research HospitalYLYing LiSt. Jude Children's Research HospitalATAimee C. TalleurSt. Jude Children's Research Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Naik et al. (2024) studied this question.

synapsesocial.com/papers/68e62eabb6db6435875c169ehttps://doi.org/10.1186/s13045-024-01567-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation2019 · 126 citations
  2. 2Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy2010 · 177 citations
  3. 3Impact of Serotherapy on Immune Reconstitution and Survival Outcomes After Stem Cell Transplantations in Children: Thymoglobulin Versus Alemtuzumab2014 · 85 citations
  4. 4Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis2022 · 33 citations